Sign In
Buy NVS
$148.93
+1.85 (+1.26%)
At Close: Jun 22, 2026
CW Advisors LLC Buys 26,009 Shares of Novartis AG $NVS
04:27am, Friday, 05'th Dec 2025
CW Advisors LLC boosted its position in Novartis AG (NYSE: NVS) by 52.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commiss
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
Here's Why Novartis (NVS) is a Strong Value Stock
10:41am, Wednesday, 03'rd Dec 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Novartis AG (NVS) Discusses Social Impact, Global Health Initiatives, and Sustainability Strategy Transcript
12:53pm, Monday, 01'st Dec 2025
Novartis AG (NVS) Discusses Social Impact, Global Health Initiatives, and Sustainability Strategy Transcript
Moderna stock slides as FDA moves to tighten vaccine guidelines
07:44am, Monday, 01'st Dec 2025
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement stricter approval...
Boston Partners Raises Position in Novartis AG $NVS
04:38am, Saturday, 29'th Nov 2025
Boston Partners lifted its stake in Novartis AG (NYSE: NVS) by 27.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional
Here's Why Novartis (NVS) is a Strong Momentum Stock
10:51am, Thursday, 27'th Nov 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Novartis (NYSE:NVS) Shares Unloaded Rep. Lisa C. McClain
02:06am, Thursday, 27'th Nov 2025
Representative Lisa C. McClain (R-Michigan) recently sold shares of Novartis AG (NYSE: NVS). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and
Market Today: Stocks Rally, Tesla Robotaxi and Nvidia Scrutiny
05:35pm, Wednesday, 26'th Nov 2025
Stock News Campbell's exec ousted after viral recording: Campbell Soup (CPB) said it terminated IT VP Martin Bally after an internal review concluded he was the
First Look: Campbell Soup fallout, Alphabet AI strength, Nvidia rebuttal
07:39am, Wednesday, 26'th Nov 2025
Stock News Campbell puts exec on leave: Campbell's Co. (CPB) sidelined a senior IT executive after a lawsuit and leaked audio alleged he disparaged customers an
Why Novartis Stock Topped the Market Today
07:17pm, Tuesday, 25'th Nov 2025
It earned FDA approval for a spinal muscular atrophy drug. This is a version of its existing commercialized SMA treatment, Zolgensma.
Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records
06:00pm, Tuesday, 25'th Nov 2025
Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price
FDA Greenlights Novartis' Gene Replacement Treatment for SMA
03:00pm, Tuesday, 25'th Nov 2025
Novartis secures FDA approval for Itvisma, a one-time gene therapy designed to boost motor function across a broad SMA patient group.
FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults
10:14am, Tuesday, 25'th Nov 2025
On Monday, the U.S. Food and Drug Administration (FDA) approved Novartis AG's (NYSE: NVS) Itvisma (onasemnogene abeparvovec-brve) for children two years and older, teens, and adults with spinal muscu
Novartis plans to cut up to 550 jobs at Swiss facility
04:02am, Tuesday, 25'th Nov 2025
Novartis said on Tuesday up to 550 full-time jobs could be cut by the end of 2027 at the Swiss pharmaceutical company's Stein facility near Basel in northern Switzerland.
